Standard BioTools Inc. (LAB)
NASDAQ: LAB · IEX Real-Time Price · USD
1.68
-0.27 (-13.85%)
May 25, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 130.58 | 138.14 | 117.24 | 112.96 | 101.94 | 104.45 | 114.71 | 116.46 | 71.18 | 52.33 | Upgrade |
| Revenue Growth (YoY) | -5.47% | 17.83% | 3.79% | 10.82% | -2.40% | -8.95% | -1.50% | 63.60% | 36.02% | - | Upgrade |
| Cost of Revenue | 61.21 | 54.82 | 52.96 | 51.32 | 49.96 | 46.01 | 46.63 | 42.85 | 20.2 | 15.33 | Upgrade |
| Gross Profit | 69.37 | 83.33 | 64.28 | 61.65 | 51.98 | 58.44 | 68.08 | 73.61 | 50.98 | 37.01 | Upgrade |
| Selling, General & Admin | 98.89 | 97.9 | 84.48 | 79.78 | 79.52 | 93.21 | 82.96 | 71.32 | 48.41 | 38.48 | Upgrade |
| Research & Development | 37.94 | 36.46 | 31.64 | 30.03 | 30.83 | 38.42 | 39.26 | 43.42 | 19.95 | 16.6 | Upgrade |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -3.99 | 10.7 | 1.27 | 0 | Upgrade |
| Operating Expenses | 136.83 | 134.36 | 116.12 | 109.81 | 110.34 | 131.63 | 118.24 | 125.44 | 69.63 | 55.08 | Upgrade |
| Operating Income | -67.46 | -51.04 | -51.84 | -48.16 | -58.36 | -73.19 | -50.16 | -51.84 | -18.65 | -18.07 | Upgrade |
| Interest Expense / Income | 3.82 | 3.57 | 4.28 | 13.89 | 5.82 | 5.82 | 5.81 | 5.34 | 0.01 | 0.63 | Upgrade |
| Other Expense / Income | -7.62 | -0.51 | 10.59 | -0.64 | -0.39 | 1.17 | -1.17 | 0.53 | -2.28 | 0.19 | Upgrade |
| Pretax Income | -63.66 | -54.1 | -66.71 | -61.42 | -63.8 | -80.18 | -54.79 | -57.71 | -16.39 | -18.89 | Upgrade |
| Income Tax | -4.42 | -1.08 | -1.92 | -2.41 | -3.26 | -4.19 | -1.48 | -4.88 | 0.14 | 0.14 | Upgrade |
| Net Income | -59.24 | -53.02 | -64.79 | -59.01 | -60.54 | -75.99 | -53.32 | -52.83 | -16.53 | -19.02 | Upgrade |
| Net Income Common | -59.24 | -53.02 | -64.79 | -59.01 | -60.54 | -75.99 | -53.32 | -52.83 | -16.53 | -19.02 | Upgrade |
| Shares Outstanding (Basic) | 76 | 72 | 67 | 40 | 33 | 29 | 29 | 28 | 25 | 22 | Upgrade |
| Shares Outstanding (Diluted) | 76 | 72 | 67 | 40 | 33 | 29 | 29 | 28 | 25 | 22 | Upgrade |
| Shares Change | 5.19% | 7.88% | 68.41% | 20.23% | 13.69% | 1.03% | 3.40% | 8.98% | 15.10% | - | Upgrade |
| EPS (Basic) | -0.78 | -0.74 | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 | -1.90 | -0.65 | -0.86 | Upgrade |
| EPS (Diluted) | -0.78 | -0.74 | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 | -1.90 | -0.65 | -0.86 | Upgrade |
| Free Cash Flow Per Share | -0.76 | -0.39 | -0.56 | -0.65 | -0.78 | -1.52 | -1.35 | -1.08 | -0.20 | -0.90 | Upgrade |
| Gross Margin | 53.13% | 60.32% | 54.83% | 54.57% | 50.99% | 55.95% | 59.35% | 63.21% | 71.62% | 70.72% | Upgrade |
| Operating Margin | -51.66% | -36.94% | -44.22% | -42.64% | -57.25% | -70.07% | -43.72% | -44.51% | -26.20% | -34.53% | Upgrade |
| Profit Margin | -45.36% | -38.38% | -55.26% | -52.24% | -59.38% | -72.75% | -46.48% | -45.36% | -23.22% | -36.35% | Upgrade |
| Free Cash Flow Margin | -43.90% | -20.37% | -32.19% | -22.64% | -25.18% | -42.32% | -33.75% | -25.78% | -7.08% | -37.95% | Upgrade |
| Effective Tax Rate | 6.95% | 2.00% | 2.87% | 3.92% | 5.12% | 5.23% | 2.69% | 8.45% | -0.84% | -0.72% | Upgrade |
| EBITDA | -55.69 | -44.5 | -58.34 | -42.16 | -50.57 | -67.62 | -44.07 | -48.3 | -13.82 | -16.07 | Upgrade |
| EBITDA Margin | -42.65% | -32.21% | -49.76% | -37.32% | -49.61% | -64.74% | -38.42% | -41.47% | -19.42% | -30.70% | Upgrade |
| EBIT | -59.84 | -50.53 | -62.43 | -47.53 | -57.98 | -74.36 | -48.98 | -52.36 | -16.38 | -18.26 | Upgrade |
| EBIT Margin | -45.82% | -36.58% | -53.24% | -42.07% | -56.87% | -71.19% | -42.70% | -44.96% | -23.00% | -34.89% | Upgrade |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).